Importantly for breast cancer, aromatase—the rate-limiting enzyme for estrogen biosynthesis—is stimulated in the adipose tissue by adipose-derived factors (IL-1β, IL-6, TNF-α, and prostaglandin (PG) E2) as well as liver-derived IGF-1 [22]. This evidence concerns the gene CYP19A1 and breast carcinoma.